Found 36 matching trials
Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study PHASE4 This is a 128-week open-label study to assess the long-term safety and tole...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Semaglutide in Auto-HSCT PHASE2 The primary objective of this clinical trial is to ievaluate the effect of ...
Show More Location
Multiple Locations
Learn More & Join Trial
G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes PHASE3 This is a non-inferiority, multi-center, randomized, controlled, single-bli...
Show More Learn More & Join Trial
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia (ODYSSEY COMBO I) PHASE3 Alirocumab (SAR236553/REGN727) is a fully human monoclonal antibody that bi...
Show More Location
Investigational Site Number 840857
Learn More & Join Trial
Detection of Usability Errors of a Medical Device Zeneo® NA The research addresses the question of the number of participants needed to...
Show More Location
Usability Lab of CIC IT 1403
Learn More & Join Trial
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy PHASE3 The purpose of this study is to evaluate the benefits and risks of lixisena...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial
Multislice Computed Tomography Assessment of PCSK9 Inhibition on Coronary Perfusion PHASE4 The MARKOV study is an investigator-sponsored single arm, prospective study...
Show More Location
Multiple Locations
Learn More & Join Trial
Vascular Effects of Alirocumab in Acute MI-Patients PHASE3 Coronary artery disease (CAD) is the most frequent cause of mortality in th...
Show More Location
University Hospital Vienna (AKH)
Learn More & Join Trial
Symptoms Control and adhErenCe Assessment During Treatment With MepolizUmab New pREfilled Devices PHASE4 Asthma is a common pathology, with a prevalence of 6 to 8% and more than 4 ...
Show More Status
Active Not Recruiting
Location
Service de Pneumologie CHU Besançon
Learn More & Join Trial
Pharma-Pen (Formerly Innoject) Auto-injectory TIV PHASE1 The purpose of this study is to evaluate the safety, effectiveness, and tol...
Show More Location
Virginia Commonwealth University
Learn More & Join Trial